Compare Moderna, Inc. (MRNA) vs Western Alliance Bancorporation (WAL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Moderna, Inc. vs Western Alliance Bancorporation — how do they compare? Moderna, Inc. trades at $59.73 (market cap $23.60B), while Western Alliance Bancorporation trades at $79.8 (market cap $8.84B). The key difference: Moderna, Inc. is far larger — about 2.7× Western Alliance Bancorporation's market cap, and Western Alliance Bancorporation pays a 2.07% dividend while Moderna, Inc. pays none. Which is the better fit depends on your goals.
| MRNA | WAL | |
|---|---|---|
Market Cap | $23.60B | $8.84B |
Sector | Health | Financials |
52-Week High | $81.80 | $96.08 |
52-Week Low | $22.36 | $66.70 |
Enterprise Value | $19.70B | — |
Dividend Yield | — | 2.07% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →About Western Alliance Bancorporation
Western Alliance Bancorporation is a top-performing bank holding company that operates a dual business model: high-touch regional banking and specialized national business lines. It serves niche industries—including technology, life sciences, and homeowners associations—providing sophisticated commercial lending and treasury solutions that bridge the gap between regional service and national scale.
Read more on WAL →
